Psychedelic Medicine Overview - What is Psychedelic Therapy + Three of My Favorite Psychedelic Research Studies

06/27/21 • 36 min

What exactly is psychedelic therapy, and what does the research on psychedelic therapy tell us about its effectiveness?

In this episode of The Integration Conversation, Brom provides a description of what exactly happens during psychedelic therapy, and then goes over the three most compelling clinical research papers on psychedelic therapy.

Learn about how MDMA can treat Post Traumatic Stress Disorder, psilocybin can treat depression, and how psilocybin stacks up against SSRIs like Lexapro.

👇 studies mentioned in this video

MDMA for PTSD https://www.nature.com/articles/s41591-021-01336-3

Trial of Psilocybin versus Escitalopram for Depression

https://www.nejm.org/doi/full/10.1056/NEJMoa2032994

Psilocybin to treat Depression and Anxiety in Cancer patients

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/

Psilocybin for smoking Cessation

https://files.csp.org/Psilocybin/Johnson2017Smoking.pdf

Ibogaine for Opioid Dependence

https://pubmed.ncbi.nlm.nih.gov/28402682/

What exactly is psychedelic therapy, and what does the research on psychedelic therapy tell us about its effectiveness?

Learn about how MDMA can treat Post Traumatic Stress Disorder, psilocybin can treat depression, and how psilocybin stacks up against SSRIs like Lexapro.

👇 studies mentioned in this video

MDMA for PTSD https://www.nature.com/articles/s41591-021-01336-3

Trial of Psilocybin versus Escitalopram for Depression

https://www.nejm.org/doi/full/10.1056/NEJMoa2032994

Psilocybin to treat Depression and Anxiety in Cancer patients

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/

Psilocybin for smoking Cessation

https://files.csp.org/Psilocybin/Johnson2017Smoking.pdf

Ibogaine for Opioid Dependence

https://pubmed.ncbi.nlm.nih.gov/28402682/

Previous Episode

Investing in Psychedelic Medicine FAQ

In this episode of The Integration Conversion, brom give a broad overview of the psychedelic investing landspace, and addresses come common misconceptions about investing in psychedelics.

Topics Include:

What does "investing in psychedelics" actually mean?
How big could the psychedelics market get?
What problems are psychedelics solving?
What are the different sub-segments of the psychedelic industry
Why is now the right time to get involved in the psychedelics industry?
Won't decriminalization destroy profits?
Aren't psychedelics just cannabis 2.0?

⏰ Timestamps:

0:00 - intro
5:00 - What exactly is "investing in psychedelics"?
8:00 - How is mental health currently treated?
10:00 - Mental health is trending in the wrong direction.
13:00 - How are psychedelics different?
13:45 - What types of businesses exist in the psychedelics industry?
20:00 - How to evaluate a psychedelic business?
22:30 - What business models should be avoided?
24:30 - Why is now the right time to invest in psychedelics?
27:30 - Is psychedelics just cannabis 2.0?
31:30 - Won't decriminalization destroy profits?

Next Episode

27: Juan Pablo Cappello - CEO of Nue Life

Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the integration of tech.

Check out Nue.Life here: https://nue.life/

⏰ Timestamps:

0:00 intro and Juan Pablo’s backstory

5:30 how Nue Life got started

11:00 the Nue Life patient experience

20:40 the intersection of data and mental health

32:30 competition in the Ketamine landscape

37:00 is ketamine addictive?

45:00 the future of at-home ketamine and the Ryan Haight act

49:15 legal psilocybin in Oregon?

53:30 what’s next for Nue Life?